Department of Psychiatry, University of Pittsburgh School of Medicine, UPMC Center for Integrative Medicine, 580 S. Aiken Avenue, Suite 310, Pittsburgh, PA 15232, USA.
Department of Psychiatry and Physical Medicine and Rehabilitation, University of Pittsburgh School of Medicine, Medical Director, UPMC Center for Integrative Medicine, 580 S. Aiken Avenue, Suite 310, Pittsburgh, PA 15232, USA.
Evid Based Complement Alternat Med. 2013;2013:613797. doi: 10.1155/2013/613797. Epub 2013 Dec 19.
CAM therapies are often dismissed as "no better than placebo;" however, this belief may be overcome through careful analysis of nonspecific factors in healing. To improve trial methodology, we propose that CAM (and conventional) RCTs should evaluate and adjust for the effects of intrapersonal, interpersonal, and environmental factors on outcomes. However, measurement of these is challenging, and there are no brief, precise instruments that are suitable for widespread use in trials and clinical settings. This paper describes the methodology of a project to develop a set of patient-reported instruments that will quantify the nonspecific or "placebo" effects that are in fact specific and active ingredients in healing. The project uses the rigorous instrument-development methodology of the NIH-PROMIS initiative. The methods include (1) integration of patients' and clinicians' opinions with existing literature; (2) development of relevant items; (3) calibration of items on large samples; (4) classical test theory and modern psychometric methods to select the most useful items; (5) development of computerized adaptive tests (CATs) that maximize information while minimizing patient burden; and (6) initial validation studies. The instruments will have the potential to revolutionize clinical trials in both CAM and conventional medicine through quantifying contextual factors that contribute to healing.
CAM 疗法常被视为“不比安慰剂好”;然而,通过仔细分析愈合过程中的非特异性因素,这种信念可能会被克服。为了改进试验方法,我们建议 CAM(和常规)RCT 应评估和调整人际、人际和环境因素对结果的影响。然而,这些因素的测量具有挑战性,而且没有简短、精确的仪器适合在试验和临床环境中广泛使用。本文介绍了一个项目的方法学,该项目旨在开发一组患者报告的工具,这些工具将量化非特异性或“安慰剂”效应,这些效应实际上是愈合的特定和有效成分。该项目使用了 NIH-PROMIS 计划的严格仪器开发方法。这些方法包括:(1)整合患者和临床医生的意见与现有文献;(2)开发相关项目;(3)在大样本中校准项目;(4)使用经典测试理论和现代心理测量方法选择最有用的项目;(5)开发计算机自适应测试 (CAT),最大限度地利用信息,同时最大限度地减少患者负担;以及(6)初步验证研究。这些工具将有可能通过量化促进愈合的背景因素,彻底改变 CAM 和常规医学中的临床试验。